Antonios, B., Abioye, O. F., Gorecki, G., Mao, S. S. (2026). Real-world data from the TriNetX database comparing abiraterone versus darolutamide in hormone-sensitive prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e17092